Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of Thymalfasin (Ta1) to Treat COVID-19 Infection in Patients With Lymphocytopenia

NCT04487444 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT04487444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04487444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of Thymalfasin (Ta1) to Treat COVID-19 Infection in Patients With Lymphocytopenia
Lead sponsor
Rhode Island Hospital
Phase
Phase 2
Overall status
Terminated
Start date
September 10, 2020
Completion date
February 3, 2023
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19